.png){kind=icon}
.png){kind=icon}
Return
Serotonin (5-HT): ancient signaling molecule reshaped by serotonylation in cancer
.png){kind=icon}
PRE
AI
D
D
W
Y
X
Z
DOI：10.1016/j.ceb.2026.102631.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Serotonin (5-HT), a conserved monoamine derived from tryptophan metabolism, has emerged as a multifaceted regulator in cancer biology. Beyond receptor signaling, serotonylation allows transglutaminase 2 (TGM2) to covalently incorporate serotonin into target proteins, linking intracellular serotonin availability to regulation of tumor metabolism, chromatin state, and immune function. Despite recent progress, the determinants of substrate selection and the physiological scope of serotonylation remain incompletely defined. In this review, we integrate advances in serotonin metabolism and receptor signaling with emerging insights into serotonylation, emphasizing its roles in tumors and the tumor microenvironment, and outline priorities for future investigation.
Keywords:
serotonin
serotonylation
cancer
TGM2
tumor microenvironment
Journal
IF:
4.3
Papers:
3.2K
Citations:
1.2W
Organization
No organization information available
Cited Papers